NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization84.64 mln
Float5.81 mln
Earnings Date11/05/2026
EPS
1.89
Decent
P / E
1.40
Deeply undervalued
Piotroski F-Score
3
/ 9
Below average
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-35.56
Deeply negative
Business Description
Dogwood Therapeutics Inc., formerly Virios Therapeutics, is a Georgia-based company founded in 2012 that develops treatments for pain and fatigue conditions. Its pipeline includes several drug candidates at various stages of testing, covering fibromyalgia, nerve pain caused by chemotherapy, cancer pain, and herpesvirus-related conditions. The company's approach often involves combining existing medications to achieve stronger therapeutic effects.
